O	O	0	11	Multifactor	Multifactor	B-NP	NN	O	2	NMOD	O
O	O	12	15	cis	cis	I-NP	NN	O	6	NMOD	O
O	O	15	16	-	-	B-NP	HYPH	O	6	NMOD	O
O	O	16	24	dominant	dominant	I-NP	JJ	O	6	NMOD	O
O	O	25	33	negative	negative	I-NP	JJ	O	6	NMOD	O
O	O	34	44	regulation	regulation	I-NP	NN	O	0	ROOT	O
O	O	45	47	of	of	B-PP	IN	O	6	NMOD	O
T1	B-Protein	48	50	IL	IL	B-NP	NN	B-DNA	12	NMOD	B-DNA
T1	I-Protein	50	51	-	-	B-NP	HYPH	I-DNA	8	NMOD	I-DNA
T1	I-Protein	51	52	2	2	I-NP	CD	I-DNA	12	NMOD	I-DNA
O	O	53	57	gene	gene	I-NP	NN	I-DNA	12	NMOD	I-DNA
O	O	58	68	expression	expression	I-NP	NN	O	7	PMOD	O
O	O	69	71	in	in	B-PP	IN	O	6	NMOD	O
O	O	72	81	anergized	anergize	B-NP	VBN	B-cell_type	16	NMOD	B-cell_type
O	O	82	83	T	T	I-NP	NN	I-cell_type	16	NMOD	I-cell_type
O	O	84	89	cells	cell	I-NP	NNS	I-cell_type	13	PMOD	I-cell_type
O	O	89	90	.	.	O	.	O	6	P	O

O	O	92	95	The	The	B-NP	DT	O	3	NMOD	O
O	O	96	105	molecular	molecular	I-NP	JJ	O	3	NMOD	O
O	O	106	115	mechanism	mechanism	I-NP	NN	O	15	SUB	O
O	O	116	126	underlying	underlie	B-VP	VBG	O	3	NMOD	O
T2	B-Protein	127	129	IL	IL	B-NP	NN	B-protein	9	NMOD	B-protein
T2	I-Protein	129	130	-	-	I-NP	HYPH	I-protein	5	NMOD	I-protein
T2	I-Protein	130	131	2	2	I-NP	CD	I-protein	5	NMOD	I-protein
O	O	132	147	transcriptional	transcriptional	I-NP	JJ	O	9	NMOD	O
O	O	148	156	blockade	blockade	I-NP	NN	O	4	OBJ	O
O	O	157	159	in	in	B-PP	IN	O	9	NMOD	O
O	O	160	167	anergic	anergic	B-NP	JJ	B-cell_line	14	NMOD	B-cell_line
O	O	168	169	T	T	I-NP	NN	I-cell_line	14	NMOD	I-cell_line
O	O	170	174	cell	cell	I-NP	NN	I-cell_line	14	NMOD	I-cell_line
O	O	175	181	clones	clone	I-NP	NNS	I-cell_line	10	PMOD	I-cell_line
O	O	182	184	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	185	188	not	not	I-VP	RB	O	15	VMOD	O
O	O	189	194	fully	fully	I-VP	RB	O	15	VMOD	O
O	O	195	205	understood	understand	I-VP	VBN	O	15	VC	O
O	O	205	206	.	.	O	.	O	15	P	O

O	O	207	209	To	To	B-VP	TO	O	2	VMOD	O
O	O	210	217	examine	examine	I-VP	VB	O	12	VMOD	O
O	O	218	225	whether	whether	B-SBAR	IN	O	2	VMOD	O
O	O	226	228	an	an	B-NP	DT	O	8	NMOD	O
O	O	229	235	active	active	I-NP	JJ	O	8	NMOD	O
O	O	236	244	negative	negative	I-NP	JJ	O	8	NMOD	O
O	O	245	255	regulatory	regulatory	I-NP	JJ	O	8	NMOD	O
O	O	256	263	process	process	I-NP	NN	O	9	SUB	O
O	O	264	270	occurs	occur	B-VP	VBZ	O	3	SBAR	O
O	O	270	271	,	,	O	,	O	12	P	O
O	O	272	274	we	we	B-NP	PRP	O	12	SUB	O
O	O	275	282	created	create	B-VP	VBD	O	0	ROOT	O
O	O	283	284	a	a	B-NP	DT	O	15	NMOD	O
O	O	285	293	reporter	reporter	I-NP	NN	B-DNA	15	NMOD	B-DNA
O	O	294	303	construct	construct	I-NP	NN	I-DNA	12	OBJ	I-DNA
O	O	304	314	containing	contain	B-VP	VBG	O	15	NMOD	O
O	O	315	317	as	as	B-PP	IN	O	16	VMOD	O
O	O	318	320	an	an	B-NP	DT	O	19	NMOD	O
T6	B-Entity	321	329	enhancer	enhancer	I-NP	NN	O	17	PMOD	O
O	O	330	334	four	four	B-NP	CD	O	21	NMOD	O
O	O	335	341	copies	copy	I-NP	NNS	O	30	NMOD	O
O	O	342	344	of	of	B-PP	IN	O	21	NMOD	O
O	O	345	348	the	the	B-NP	DT	O	27	NMOD	O
T7	B-Entity	349	351	NF	NF	I-NP	NN	B-DNA	27	NMOD	B-DNA
T7	I-Entity	351	352	-	-	B-NP	HYPH	I-DNA	27	NMOD	I-DNA
T7	I-Entity	352	354	AT	AT	I-NP	NN	I-DNA	27	NMOD	I-DNA
T7	I-Entity	355	359	site	site	I-NP	NN	I-DNA	22	PMOD	I-DNA
O	O	360	363	and	and	O	CC	O	30	NMOD	O
O	O	364	367	one	one	B-NP	CD	O	30	NMOD	O
O	O	368	372	copy	copy	I-NP	NN	O	16	OBJ	O
O	O	373	375	of	of	B-PP	IN	O	30	NMOD	O
O	O	376	379	the	the	B-NP	DT	O	34	NMOD	O
T8	B-Entity	380	387	octamer	octamer	I-NP	NN	B-DNA	34	NMOD	B-DNA
T8	I-Entity	388	392	site	site	I-NP	NN	I-DNA	31	PMOD	I-DNA
O	O	393	394	(	(	O	(	O	42	DEP	O
T9	B-Entity	394	396	4X	4X	B-NP	NN	O	39	NMOD	O
T9	I-Entity	397	399	NF	NF	I-NP	NN	B-protein	39	NMOD	B-protein
T9	I-Entity	399	400	-	-	B-NP	HYPH	I-protein	39	P	I-protein
T9	I-Entity	400	402	AT	AT	I-NP	NN	I-protein	41	NMOD	I-protein
T9	I-Entity	402	403	-	-	B-NP	HYPH	O	41	P	O
T9	I-Entity	403	406	Oct	Oct	I-NP	NN	B-DNA	42	DEP	B-DNA
O	O	406	407	)	)	O	)	O	30	NMOD	O
O	O	407	408	.	.	O	.	O	12	P	O

O	O	409	413	This	This	B-NP	DT	O	2	NMOD	O
O	O	414	423	construct	construct	I-NP	NN	O	3	SUB	O
O	O	424	427	was	be	B-VP	VBD	O	0	ROOT	O
O	O	428	432	only	only	I-VP	RB	O	3	VMOD	O
O	O	433	441	slightly	slightly	I-VP	RB	O	4	AMOD	O
O	O	442	449	reduced	reduce	I-VP	VBN	O	3	VC	O
O	O	450	451	(	(	O	(	O	13	DEP	O
O	O	451	452	1	1	B-NP	CD	O	10	NMOD	O
O	O	452	453	.	.	I-NP	.	O	8	P	O
O	O	453	454	3	3	I-NP	CD	O	13	DEP	O
O	O	454	455	-	-	O	HYPH	O	10	P	O
O	O	455	459	fold	fold	B-ADVP	RB	O	10	NMOD	O
O	O	459	460	)	)	O	)	O	6	VMOD	O
O	O	461	463	in	in	B-PP	IN	O	6	VMOD	O
O	O	464	467	its	its	B-NP	PRP$	O	16	NMOD	O
O	O	468	478	expression	expression	I-NP	NN	O	14	PMOD	O
O	O	479	483	when	when	B-ADVP	WRB	O	6	VMOD	O
O	O	484	494	stimulated	stimulate	B-VP	VBN	O	17	SBAR	O
O	O	495	500	under	under	B-PP	IN	O	18	VMOD	O
O	O	501	508	anergic	anergic	B-NP	JJ	O	21	NMOD	O
O	O	509	519	conditions	condition	I-NP	NNS	O	19	PMOD	O
O	O	519	520	,	,	O	,	O	3	P	O
O	O	521	526	while	while	B-SBAR	IN	O	3	VMOD	O
O	O	527	528	a	a	B-NP	DT	O	31	NMOD	O
O	O	529	534	whole	whole	I-NP	JJ	O	31	NMOD	O
O	O	535	540	mouse	mouse	I-NP	NN	B-DNA	31	NMOD	B-DNA
T3	B-Protein	541	543	IL	IL	I-NP	NN	I-DNA	31	NMOD	I-DNA
T3	I-Protein	543	544	-	-	B-NP	HYPH	I-DNA	31	NMOD	I-DNA
T3	I-Protein	544	545	2	2	I-NP	CD	I-DNA	31	NMOD	I-DNA
T10	B-Entity	546	554	enhancer	enhancer	I-NP	NN	I-DNA	31	NMOD	I-DNA
O	O	555	564	construct	construct	I-NP	NN	I-DNA	32	SUB	I-DNA
O	O	565	571	showed	show	B-VP	VBD	O	23	SBAR	O
O	O	572	573	a	a	B-NP	DT	O	34	NMOD	O
O	O	574	583	reduction	reduction	I-NP	NN	O	32	OBJ	O
O	O	584	586	of	of	B-PP	IN	O	34	NMOD	O
O	O	587	588	4	4	B-NP	CD	O	35	PMOD	O
O	O	588	589	.	.	I-NP	.	O	36	P	O
O	O	589	590	3	3	I-NP	CD	O	36	NMOD	O
O	O	590	591	-	-	B-VP	HYPH	O	36	NMOD	O
O	O	591	595	fold	fold	B-ADVP	RB	O	39	VMOD	O
O	O	595	596	.	.	O	.	O	3	P	O

O	O	597	605	Addition	Addition	B-NP	NN	O	19	SUB	O
O	O	606	608	of	of	B-PP	IN	O	1	NMOD	O
O	O	609	612	the	the	B-NP	DT	O	5	NMOD	O
T11	B-Entity	613	614	-	-	I-NP	SYM	B-DNA	5	AMOD	B-DNA
T11	I-Entity	614	617	176	176	I-NP	CD	I-DNA	2	PMOD	I-DNA
T11	I-Entity	618	620	to	to	B-PP	TO	I-DNA	1	NMOD	I-DNA
T11	I-Entity	621	622	-	-	B-NP	SYM	I-DNA	9	NMOD	I-DNA
T11	I-Entity	622	624	96	96	I-NP	CD	I-DNA	9	NMOD	I-DNA
T11	I-Entity	625	633	sequence	sequence	I-NP	NN	I-DNA	6	PMOD	I-DNA
O	O	634	636	to	to	B-PP	TO	O	1	NMOD	O
O	O	637	640	the	the	B-NP	DT	O	18	NMOD	O
T12	B-Entity	641	643	4X	4X	I-NP	NN	O	15	NMOD	O
T12	I-Entity	644	646	NF	NF	I-NP	NN	B-protein	15	NMOD	B-protein
T12	I-Entity	646	647	-	-	B-NP	HYPH	I-protein	15	P	I-protein
T12	I-Entity	647	649	AT	AT	I-NP	NN	I-protein	18	NMOD	I-protein
T12	I-Entity	649	650	-	-	B-NP	HYPH	O	18	NMOD	O
T12	I-Entity	650	653	Oct	Oct	I-NP	NN	B-DNA	18	NMOD	B-DNA
O	O	654	663	construct	construct	I-NP	NN	I-DNA	10	PMOD	I-DNA
O	O	664	667	did	do	B-VP	VBD	O	40	VMOD	O
O	O	668	671	not	not	I-VP	RB	O	19	VMOD	O
O	O	672	678	impart	impart	I-VP	VB	O	19	VC	O
O	O	679	682	the	the	B-NP	DT	O	23	NMOD	O
O	O	683	690	ability	ability	I-NP	NN	O	21	OBJ	O
O	O	691	693	to	to	B-VP	TO	O	25	VMOD	O
O	O	694	696	be	be	I-VP	VB	O	23	NMOD	O
O	O	697	705	affected	affect	I-VP	VBN	O	25	VC	O
O	O	706	708	by	by	B-PP	IN	O	26	VMOD	O
O	O	709	715	anergy	anergy	B-NP	NN	O	27	PMOD	O
O	O	715	716	,	,	O	,	O	40	P	O
O	O	717	720	but	but	O	CC	O	40	VMOD	O
O	O	721	729	addition	addition	B-NP	NN	O	40	SUB	O
O	O	730	732	of	of	B-PP	IN	O	31	NMOD	O
O	O	733	736	the	the	B-NP	DT	O	35	NMOD	O
T13	B-Entity	737	738	-	-	I-NP	SYM	B-DNA	35	AMOD	B-DNA
T13	I-Entity	738	741	236	236	I-NP	CD	I-DNA	32	PMOD	I-DNA
T13	I-Entity	742	744	to	to	B-PP	TO	I-DNA	32	PMOD	I-DNA
T13	I-Entity	745	746	-	-	B-NP	SYM	I-DNA	39	NMOD	I-DNA
T13	I-Entity	746	748	96	96	I-NP	CD	I-DNA	39	NMOD	I-DNA
T13	I-Entity	749	757	sequence	sequence	I-NP	NN	I-DNA	36	PMOD	I-DNA
O	O	758	761	did	do	B-VP	VBD	O	0	ROOT	O
O	O	761	762	,	,	O	,	O	40	P	O
O	O	763	776	demonstrating	demonstrate	B-VP	VBG	O	40	VMOD	O
O	O	777	781	that	that	B-SBAR	IN	O	51	DEP	O
O	O	782	788	anergy	anergy	B-NP	NN	O	45	SUB	O
O	O	789	791	is	be	B-VP	VBZ	O	43	SBAR	O
O	O	792	794	an	an	B-NP	DT	O	49	NMOD	O
O	O	795	801	active	active	I-NP	JJ	O	49	NMOD	O
O	O	802	812	inhibitory	inhibitory	I-NP	JJ	O	49	NMOD	O
O	O	813	820	process	process	I-NP	NN	O	45	PRD	O
O	O	821	824	and	and	O	CC	O	51	DEP	O
O	O	825	829	that	that	B-SBAR	IN	O	42	VMOD	O
O	O	830	834	more	more	B-NP	JJR	O	72	SUB	O
O	O	835	839	than	than	B-PP	IN	O	52	NMOD	O
O	O	840	843	the	the	B-NP	DT	O	55	NMOD	O
O	O	844	852	presence	presence	I-NP	NN	O	53	PMOD	O
O	O	853	855	of	of	B-PP	IN	O	55	NMOD	O
O	O	856	859	the	the	B-NP	DT	O	64	NMOD	O
T14	B-Entity	860	861	-	-	I-NP	SYM	B-DNA	64	NMOD	B-DNA
T14	I-Entity	861	864	150	150	I-NP	CD	I-DNA	64	NMOD	I-DNA
T14	I-Entity	865	867	AP	AP	I-NP	NN	I-DNA	64	NMOD	I-DNA
T14	I-Entity	867	868	-	-	B-NP	HYPH	I-DNA	64	NMOD	I-DNA
T14	I-Entity	868	869	1	1	I-NP	CD	I-DNA	64	NMOD	I-DNA
T14	I-Entity	870	877	binding	bind	I-NP	VBG	I-DNA	64	NMOD	I-DNA
T14	I-Entity	878	882	site	site	I-NP	NN	I-DNA	56	PMOD	I-DNA
O	O	883	884	(	(	O	(	O	71	DEP	O
T15	B-Entity	884	885	-	-	B-NP	SYM	B-DNA	70	NMOD	B-DNA
T15	I-Entity	885	888	152	152	B-NP	CD	I-DNA	70	NMOD	I-DNA
T15	I-Entity	889	891	to	to	B-PP	TO	I-DNA	70	NMOD	I-DNA
T15	I-Entity	892	893	-	-	B-NP	SYM	I-DNA	70	NMOD	I-DNA
T15	I-Entity	893	896	147	147	I-NP	CD	I-DNA	71	DEP	I-DNA
O	O	896	897	)	)	O	)	O	64	NMOD	O
O	O	898	900	is	be	B-VP	VBZ	O	51	SBAR	O
O	O	901	909	required	require	I-VP	VBN	O	72	VC	O
O	O	910	912	to	to	I-VP	TO	O	75	VMOD	O
O	O	913	920	mediate	mediate	I-VP	VB	O	73	VMOD	O
O	O	921	924	the	the	B-NP	DT	O	77	NMOD	O
O	O	925	931	effect	effect	I-NP	NN	O	75	OBJ	O
O	O	931	932	.	.	O	.	O	40	P	O

O	O	933	943	Mutational	Mutational	B-NP	JJ	O	2	NMOD	O
O	O	944	951	studies	study	I-NP	NNS	O	11	SUB	O
O	O	952	954	of	of	B-PP	IN	O	2	NMOD	O
O	O	955	958	the	the	B-NP	DT	O	6	NMOD	O
T16	B-Entity	959	960	-	-	I-NP	SYM	B-DNA	6	AMOD	B-DNA
T16	I-Entity	960	963	236	236	I-NP	CD	I-DNA	10	NMOD	I-DNA
T16	I-Entity	964	966	to	to	B-PP	TO	I-DNA	10	NMOD	I-DNA
T16	I-Entity	967	968	-	-	B-NP	SYM	I-DNA	10	NMOD	I-DNA
T16	I-Entity	968	970	96	96	I-NP	CD	I-DNA	10	NMOD	I-DNA
T16	I-Entity	971	979	sequence	sequence	I-NP	NN	I-DNA	3	PMOD	I-DNA
O	O	980	989	indicated	indicate	B-VP	VBD	O	0	ROOT	O
O	O	990	994	that	that	B-SBAR	IN	O	11	VMOD	O
O	O	995	998	the	the	B-NP	DT	O	14	NMOD	O
O	O	999	1007	presence	presence	I-NP	NN	O	41	NMOD	O
O	O	1008	1010	of	of	B-PP	IN	O	14	NMOD	O
O	O	1011	1015	both	both	O	CC	O	25	NMOD	O
O	O	1016	1019	the	the	B-NP	DT	O	25	NMOD	O
T17	B-Entity	1020	1021	-	-	I-NP	SYM	B-DNA	25	NMOD	B-DNA
T17	I-Entity	1021	1024	130	130	I-NP	CD	I-DNA	25	NMOD	I-DNA
T17	I-Entity	1025	1027	AP	AP	I-NP	NN	I-DNA	25	NMOD	I-DNA
T17	I-Entity	1027	1028	-	-	B-NP	HYPH	I-DNA	25	NMOD	I-DNA
T17	I-Entity	1028	1029	1	1	I-NP	CD	I-DNA	25	NMOD	I-DNA
T17	I-Entity	1029	1030	-	-	I-NP	HYPH	I-DNA	25	NMOD	I-DNA
T17	I-Entity	1030	1034	like	like	I-NP	JJ	I-DNA	25	NMOD	I-DNA
T17	I-Entity	1035	1039	site	site	I-NP	NN	I-DNA	15	PMOD	I-DNA
O	O	1040	1041	(	(	O	(	O	32	DEP	O
T18	B-Entity	1041	1042	-	-	B-NP	SYM	B-DNA	31	NMOD	B-DNA
T18	I-Entity	1042	1045	187	187	B-NP	CD	I-DNA	31	NMOD	I-DNA
T18	I-Entity	1046	1048	to	to	B-PP	TO	I-DNA	31	NMOD	I-DNA
T18	I-Entity	1049	1050	-	-	B-NP	SYM	I-DNA	31	NMOD	I-DNA
T18	I-Entity	1050	1053	181	181	I-NP	CD	I-DNA	32	DEP	I-DNA
O	O	1053	1054	)	)	O	)	O	25	NMOD	O
O	O	1055	1058	and	and	O	CC	O	41	NMOD	O
O	O	1059	1062	the	the	B-NP	DT	O	41	NMOD	O
T19	B-Entity	1063	1064	-	-	I-NP	SYM	B-DNA	41	NMOD	B-DNA
T19	I-Entity	1064	1067	150	150	I-NP	CD	I-DNA	41	NMOD	I-DNA
T19	I-Entity	1068	1076	proximal	proximal	I-NP	JJ	I-DNA	41	NMOD	I-DNA
T19	I-Entity	1077	1079	AP	AP	I-NP	NN	I-DNA	41	NMOD	I-DNA
T19	I-Entity	1079	1080	-	-	B-NP	HYPH	I-DNA	41	NMOD	I-DNA
T19	I-Entity	1080	1081	1	1	I-NP	CD	I-DNA	41	NMOD	I-DNA
T19	I-Entity	1082	1086	site	site	I-NP	NN	I-DNA	42	SUB	I-DNA
O	O	1087	1091	were	be	B-VP	VBD	O	12	SBAR	O
O	O	1092	1101	necessary	necessary	B-ADJP	JJ	O	42	PRD	O
O	O	1102	1104	to	to	B-VP	TO	O	45	VMOD	O
O	O	1105	1112	observe	observe	I-VP	VB	O	43	AMOD	O
O	O	1113	1119	anergy	anergy	B-NP	NN	O	45	OBJ	O
O	O	1119	1120	.	.	O	.	O	11	P	O

O	O	1121	1128	Because	Because	B-SBAR	IN	O	15	VMOD	O
O	O	1129	1132	the	the	B-NP	DT	O	5	NMOD	O
T20	B-Entity	1133	1134	-	-	I-NP	SYM	B-DNA	5	NMOD	B-DNA
T20	I-Entity	1134	1137	180	180	I-NP	CD	I-DNA	5	NMOD	I-DNA
T20	I-Entity	1138	1142	site	site	I-NP	NN	I-DNA	6	SUB	I-DNA
O	O	1143	1145	is	be	B-VP	VBZ	O	1	SBAR	O
O	O	1146	1149	not	not	I-VP	RB	O	6	VMOD	O
O	O	1150	1158	required	require	I-VP	VBN	O	6	VC	O
O	O	1159	1162	for	for	B-PP	IN	O	8	VMOD	O
O	O	1163	1168	trans	trans	B-NP	AFX	O	12	NMOD	O
O	O	1168	1169	-	-	I-NP	HYPH	O	12	NMOD	O
O	O	1169	1179	activation	activation	B-NP	NN	O	9	PMOD	O
O	O	1179	1180	,	,	O	,	O	15	P	O
O	O	1181	1183	it	it	B-NP	PRP	O	15	SUB	O
O	O	1184	1187	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1188	1196	possible	possible	B-ADJP	JJ	O	15	PRD	O
O	O	1197	1199	to	to	B-VP	TO	O	18	VMOD	O
O	O	1200	1207	confirm	confirm	I-VP	VB	O	15	VMOD	O
O	O	1208	1210	by	by	B-PP	IN	O	18	VMOD	O
O	O	1211	1219	mutation	mutation	B-NP	NN	O	19	PMOD	O
O	O	1220	1222	in	in	B-PP	IN	O	20	NMOD	O
O	O	1223	1226	the	the	B-NP	DT	O	28	NMOD	O
O	O	1227	1233	normal	normal	I-NP	JJ	O	28	NMOD	O
T21	B-Entity	1234	1239	mouse	mouse	I-NP	NN	B-DNA	25	NMOD	B-DNA
T4,T21	B-Protein,I-Entity	1240	1242	IL	IL	I-NP	NN	I-DNA	28	NMOD	I-DNA
T4,T21	I-Protein,I-Entity	1242	1243	-	-	B-NP	HYPH	I-DNA	28	NMOD	I-DNA
T4,T21	I-Protein,I-Entity	1243	1244	2	2	I-NP	CD	I-DNA	28	NMOD	I-DNA
T21,T22	I-Entity,B-Entity	1245	1253	enhancer	enhancer	I-NP	NN	I-DNA	21	PMOD	I-DNA
O	O	1254	1258	that	that	B-SBAR	IN	O	20	NMOD	O
O	O	1259	1263	this	this	B-NP	DT	O	31	NMOD	O
O	O	1264	1268	site	site	I-NP	NN	O	32	SUB	O
O	O	1269	1271	is	be	B-VP	VBZ	O	29	SBAR	O
O	O	1272	1282	absolutely	absolutely	B-ADJP	RB	O	34	AMOD	O
O	O	1283	1292	essential	essential	I-ADJP	JJ	O	32	PRD	O
O	O	1293	1296	for	for	B-PP	IN	O	34	AMOD	O
O	O	1297	1303	anergy	anergy	B-NP	NN	O	37	NMOD	O
O	O	1304	1313	induction	induction	I-NP	NN	O	35	PMOD	O
O	O	1313	1314	.	.	O	.	O	15	P	O

O	O	1315	1318	The	The	B-NP	DT	O	3	NMOD	O
O	O	1319	1327	simplest	simple	I-NP	JJS	O	3	NMOD	O
O	O	1328	1333	model	model	I-NP	NN	O	8	SUB	O
O	O	1334	1336	to	to	B-VP	TO	O	5	VMOD	O
O	O	1337	1344	explain	explain	I-VP	VB	O	3	NMOD	O
O	O	1345	1350	these	these	B-NP	DT	O	7	NMOD	O
O	O	1351	1358	results	result	I-NP	NNS	O	5	OBJ	O
O	O	1359	1361	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	1362	1366	that	that	B-SBAR	IN	O	8	PRD	O
O	O	1367	1373	anergy	anergy	B-NP	NN	O	11	SUB	O
O	O	1374	1376	is	be	B-VP	VBZ	O	9	SBAR	O
O	O	1377	1385	mediated	mediate	I-VP	VBN	O	11	VC	O
O	O	1386	1388	by	by	B-PP	IN	O	12	VMOD	O
O	O	1389	1390	a	a	B-NP	DT	O	15	NMOD	O
T23	B-Entity	1391	1398	complex	complex	I-NP	NN	O	13	PMOD	O
T23	I-Entity	1399	1401	of	of	B-PP	IN	O	15	NMOD	O
T23	I-Entity	1402	1410	multiple	multiple	B-NP	JJ	O	19	NMOD	O
T23	I-Entity	1411	1424	transcription	transcription	I-NP	NN	B-protein	19	NMOD	B-protein
T23	I-Entity	1425	1432	factors	factor	I-NP	NNS	I-protein	16	PMOD	I-protein
O	O	1433	1437	that	that	B-NP	WDT	O	19	NMOD	O
O	O	1438	1443	exert	exert	B-VP	VBP	O	20	SBAR	O
O	O	1444	1445	a	a	B-NP	DT	O	23	NMOD	O
O	O	1446	1449	cis	cis	I-NP	NN	B-protein	21	OBJ	B-protein
O	O	1449	1450	-	-	O	HYPH	O	21	P	O
O	O	1450	1456	acting	act	B-VP	VBG	O	21	VMOD	O
O	O	1457	1465	dominant	dominant	B-NP	JJ	O	29	NMOD	O
O	O	1466	1474	negative	negative	I-NP	JJ	O	29	NMOD	O
O	O	1475	1485	regulatory	regulatory	I-NP	JJ	O	29	NMOD	O
O	O	1486	1492	effect	effect	I-NP	NN	O	25	OBJ	O
O	O	1493	1495	on	on	B-PP	IN	O	29	NMOD	O
O	O	1496	1499	the	the	B-NP	DT	O	30	PMOD	O
O	O	1500	1505	trans	trans	I-NP	AFX	O	31	NMOD	O
O	O	1505	1506	-	-	I-NP	HYPH	O	32	PMOD	O
O	O	1506	1516	activation	activation	I-NP	NN	O	33	OBJ	O
O	O	1517	1519	of	of	B-PP	IN	O	34	NMOD	O
O	O	1520	1523	the	the	B-NP	DT	O	40	NMOD	O
T5	B-Protein	1524	1526	IL	IL	I-NP	NN	B-DNA	40	NMOD	B-DNA
T5	I-Protein	1526	1527	-	-	B-NP	HYPH	I-DNA	40	NMOD	I-DNA
T5	I-Protein	1527	1528	2	2	I-NP	CD	I-DNA	40	NMOD	I-DNA
O	O	1529	1533	gene	gene	I-NP	NN	I-DNA	35	PMOD	I-DNA
O	O	1533	1534	.	.	O	.	O	8	P	O
